Overview

An Assessment of Buprenorphine Transdermal Delivery System (BTDS) Patch Adhesion

Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the adhesion of BTDS patch 40 µg/h.
Phase:
Phase 1
Details
Lead Sponsor:
Mundipharma Research Limited
Treatments:
Buprenorphine